Scholars Central

Review articlePublished 23 Aug 2022

Induced Pluripotent Stem Cell-derived Cardiomyocytes can serve as Acellular Models for Cardiac Toxicity Testing

Authors: Moyes Yuan

National Laboratory of Bio-macromolecules, Institute of Biophysics, Chinese Academy of Sciences, Chaoyang, Beijing, China

World Journal of Pharmacology and Toxicology

Volume 5 · Issue 4 · Pages 1–4

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Induced pluripotent stem cell (iPSC) science is developing thrilling new possibilities for cardiovascular lookup by way of offering structures to learn about the mechanisms of ailment pathogenesis that ought to lead to new treatments or divulge drug sensitivities. In this review, the practicable usefulness of iPSC-derived cardiomyocytes in drug improvement as nicely as in drug toxicity checking out is discussed, with a center of attention on the achievements that have been already made in this regard. Moreover, the critical steps that have to be taken earlier than this science can be widely used in drug discovery and toxicology assessments are highlighted.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in World Journal of Pharmacology and Toxicology.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalWorld Journal of Pharmacology and Toxicology
  • SubjectPharmaceutical Sciences
  • SubjectToxicology
  • BylineArticles whose byline prints “Moyes Yuan”